Navigation Links
New Study Confirms Role for Pertussis Immunization of Entire Family,in Reducing Infant Pertussis

is_t.htm. Accessed February 9, 2007. (5) CDC. Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine. MMWR 2006;55(No. RR-17):1-37 Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5517a1.htm. Accessed February 12, 2007.

CONTACT: Pascal Barollier, International Media Relations,+33-0-4-37-37-51-41, , or Len Lavenda,U.S. Media Relations, +1-570-839-4446, , bothof sanofi pasteur pascal.barollier@sanofipasteur.com len.lavenda@sanofipasteur.com

Web site: http://www.sanofipasteur.com/http://www.adacelvaccine.com/http://www.adacel-locator.com/http://www.cdc.gov/ncidod/dbmd/diseaseinfo/pertussis_t.htm/http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5517a1.htm/

Ticker Symbol: (NYSE:SNY)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:5/1/2015)... 2015   Heska Corporation (NASDAQ: HSKA ... of advanced veterinary diagnostic and other specialty veterinary products ... will present at the 16th Annual B. Riley & Co. ... The conference will be held May 12-14, 2015 at Lowes ... management will be available during the day on May 13 ...
(Date:5/1/2015)... 1, 2015 Braeburn Pharmaceuticals announced ... therapeutic focus beyond addiction and pain to ... Braeburn has acquired an implantable, six-month formulation ... for treatment of schizophrenia from Endo Pharmaceuticals. ... rights to other potential applications of the ...
(Date:5/1/2015)... , May 1, 2015  Boston Scientific Corporation (NYSE: ... continued business momentum and long-term growth strategies at a ... New York City . President and Chief Executive ... opportunities the company has to bring forward meaningful innovation ... markets and deliver shareholder value. "We ...
Breaking Medicine Technology:Heska to Present at the 16th Annual B. Riley & Co. Investor Conference 2Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 2Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 3Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 4Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 2Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 3Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 4Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 5Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 6Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 7
... 2011 The oncology market continues to be a ... all the aspects of successfully launching a new oncology ... supporting the oncology therapeutic area are constantly assessing the ... group. Best Practices, LLC, a leader in ...
... MUNDELEIN, Ill., April 19, 2011 Sysmex, a ... information systems technology, announced today an amended distributorship ... which automatically renews for up to four successive ... instruments including the Sysmex pocH-100 i™ , Sysmex ...
Cached Medicine Technology:Oncology Global Strategic Marketing Study Offers Chance for Resource Benchmarks 2Sysmex America Signs Distributorship Agreement With LABSCO 2
(Date:5/2/2015)... 02, 2015 It’s a pattern that ... disaster strikes anywhere on this planet, cyber scammers will ... and compassion for their own personal gain. And ... Readiness Team) issued an alert titled “Nepal Earthquake ... scams citing the earthquake in Nepal. The scam emails ...
(Date:5/2/2015)... East Liverpool, Ohio (PRWEB) May 02, 2015 ... of East Liverpool City Hospital (ELCH) gathered to celebrate ... direction of River Valley Health Partners (RVHP), had zero ... and zero urinary catheter associated infections. ELCH was also ... , The management team at ELCH credited the ...
(Date:5/2/2015)... ZoomCare, the Portland-based innovator of on-demand healthcare ... its new healthcare insurance to individuals and small businesses ... System is the nation’s first health insurance system built ... Personal Health Insurance was ZoomCare’s first such filing including ... to review and regulation by the Oregon Insurance Division. ...
(Date:5/1/2015)... and Caicos Islands, BWI (PRWEB) May 02, 2015 ... new website! It is http://www.thevenetiangracebay.com , and ... and it incorporates the stunning white and attractive turquoise ... a study of Google, sixty seven percent of leisure ... The study showed that smartphones were used in the ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 Royal River ... Freeport, Maine, reports on a new study that found ... joint swelling and improved physical function as well as ... severe osteoarthritis of the knee. , The report is ... Insights for Well Being® ,” which Royal River Natural ...
Breaking Medicine News(10 mins):Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2Health News:ZoomCare Applies to be on Oregon Exchange 2Health News:Turks and Caicos Resort, The Venetian on Grace Bay, Launches New Web Presence 2Health News:New Study Finds Nutrients Ease Arthritis Pain, Retailer Reports 2
... available over-the-counter in pharmacies and health food shops are ... to University of Leeds researchers. In April this ... the sale of traditional herbal medicines, such as St ... clear information on possible side effects, how they could ...
... 8 (HealthDay News) -- Students attending high schools dominated by ... a new study shows. In fact, researchers in Virginia ... (Algebra I, Earth Science and World History) were 3 percent ... more severe bullying climate. The findings, they added, highlight the ...
... HealthDay Reporter , MONDAY, Aug. 8 (HealthDay News) -- ... clots in deep veins such as those in the legs and ... a relative risk 50 times higher for developing such clots themselves, ... are two times as likely to suffer the dangerous blood clots. ...
... Care Emergency Surgical Service (ACCESS) in emergency departments (EDs) can ... length of stay, surgical decision-making time and "time-to-stretcher" (one measure ... the August issue of the Journal of the American ... of access to the health care system for patients with ...
... treatment for carpal tunnel syndrome (CTS) prefer to play a ... their medical or surgical care, according to the findings of ... and Joint Surgery (JBJS). "While other studies ... tend to prefer a more passive role when it comes ...
... (HealthDay News) -- Hammer toes, curly toes, crossover toes and bunions ... other health problems, a new report warns. According to a ... the American Academy of Orthopaedic Surgeons , deformities of the lesser ... should be treated as early as possible by an orthopaedic surgeon ...
Cached Medicine News:Health News:Herbal remedies escape EU law 2Health News:Bullying Takes Toll on High School Test Scores 2Health News:Life-Threatening Leg Clots Run in Families, Study Shows 2Health News:Life-Threatening Leg Clots Run in Families, Study Shows 3Health News:Urgent assessment in emergency departments can reduce surgical decision time and overcrowding 2Health News:Carpal tunnel syndrome patients prefer to share decision-making with their physicians 2Health News:Carpal tunnel syndrome patients prefer to share decision-making with their physicians 3Health News:Toe Deformities Should Be Treated Early: Experts 2
... automated random access immunoassay testing, comes the AIA-600 ... proven reliability of Tosohs original AIA-600, is loaded ... and continuous process operation., Test Menu: ... FT3 FT4 T-Uptake TSH 3rd ...
The FastPack system is a state of the art, lab quality immunoassay system designed for rapid results. The FastPack system delivers lab-quality sensitivity at a fraction of the cost of laboratory....
... Vitros ECi brings true automation and ... testing. Highly sensitive assays for thyroid, ... bone metabolism testing are currently available, ... The Vitros ECi can simultaneously process ...
... Vitros 250 is a flexible ... in multiple environments small ... clinics and satellite locations. The ... dilution, and can be automated ...
Medicine Products: